查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2045885

獸用免疫診斷市場－全球產業規模、佔有率、趨勢、機會與預測：按產品類型、按動物類型分類，2021-2031年

Veterinary Immunodiagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type By Animal Type, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 177 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球獸醫免疫診斷市場預計將從 2025 年的 29.4 億美元成長到 2031 年的 46.6 億美元，複合年成長率達到 7.98%。

在獸醫學的這一專業領域，抗原-抗體交互作用被用於識別傳染性病原體、測量荷爾蒙水平以及評估家畜和伴侶動物的免疫反應。該市場的成長主要受全球寵物數量不斷增加和對高效肉類生產需求日益成長的驅動，而這兩方面都要求進行嚴格的疾病監測。通用感染疾病率的上升進一步推動了這一趨勢，因此迫切需要能夠超越短暫趨勢的精準篩檢工具。該產業的經濟潛力巨大；根據美國寵物用品協會（APPA）統計，2024年美國獸醫及相關產品的銷售額將達到398億美元。

市場概覽
預測期 2027-2031
市場規模：2025年 29.4億美元
市場規模：2031年 46.6億美元
複合年成長率：2026-2031年 7.98%
成長最快的細分市場 分析器
最大的市場 北美洲

然而，先進免疫診斷檢測的高昂成本是進一步擴大市場的主要障礙，這限制了其在價格敏感地區的應用。雖然這些診斷方法在已開發市場日益普及，但經濟負擔仍然是小規模獸醫診所和開發中國家的一大障礙。此外，能夠解讀複雜診斷結果的訓練有素的獸醫專業人員短缺，也加劇了這項挑戰，進而限制了高精度免疫診斷技術的應用。

市場促進因素

寵物飼養量的激增以及人們對動物日益「擬人化」的觀念，是全球獸醫免疫診斷市場的主要驅動力，並正在改變獸醫行業的經濟結構。隨著飼主越來越將寵物視為家庭成員，他們也更願意投資於預防性護理和先進的診斷檢測。快速發展的寵物保險行業為這一趨勢提供了經濟支持，有效減輕了寵物主人承擔複雜檢測費用的負擔。根據北美寵物健康保險協會發布的《2024年產業趨勢報告》，2023年美國寵物健康保險總保費達到39億美元，實現了兩位數的成長。投保寵物數量的增加與免疫診斷檢測的普及直接相關，這使得獸醫能夠更有信心地要求飼主進行全面的診斷，並獲得保險公司的報銷。

同時，通用和動物感染疾病的日益蔓延，推動了伴侶動物和家畜對快速、高靈敏度檢測工具的需求激增。跨國病原體對感染疾病和全球糧食安全構成威脅，因此需要基於免疫診斷技術的健全監測系統。美國農業部動植物衛生檢驗局 (APHIS) 於 2024 年 4 月確認在乳牛群中檢測到高致病性禽流感後，對標靶檢測的迫切需求便是一個鮮明的例證。這些市場趨勢的規模也反映在該行業的財務表現中。 IDEXX Laboratories 在 2024 年 2 月的收益報告中揭露，2023 年的即時為 36.6 億美元，凸顯了獸醫診斷需求帶來的巨大價值。

市場挑戰

先進免疫診斷檢測的高昂成本是全球獸醫免疫診斷市場擴張的主要障礙。儘管這些診斷工具在檢測病原體和免疫反應方面具有很高的準確性，但其高昂的價格極大地限制了它們的普及，尤其是在價格敏感地區和小規模獨立動物醫院。這種經濟障礙迫使獸醫和畜牧養殖戶優先考慮必要的治療而非嚴格的篩檢，導致檢測的使用率降低。因此，市場面臨瓶頸：檢測疾病的技術能力已經具備，但大規模部署這些工具的經濟能力卻不足，這阻礙了開發中國家潛在的收入來源。

這種經濟負擔與獸醫參與度的下降直接相關，從而抑制了對診斷服務的整體需求。當寵物飼主和繁殖者面臨不斷飆升的醫療保健成本時，常規體檢和診斷就診往往首當其衝被削減。根據美國獸醫協會（AVMA）預測，2024年獸醫診所的就診量較去年同期下降了2.3%。就診量的下降必然導致診斷檢測項目的減少，直接縮小了免疫診斷產品的潛在目標市場。只要這些檢測對全球獸醫行業的大部分人來說仍然難以負擔，市場成長軌跡就將繼續受到這些價格障礙的限制。

市場趨勢

基於生物感測器的免疫診斷技術的出現正在革新獸醫學，使臨床環境能夠直接提供實驗室層級的精確度。與傳統的橫向流動化驗不同，這些先進的平台利用體聲波（BAW）感測器等技術，以更高的靈敏度檢測荷爾蒙和病原體。這使得獸醫能夠在患者就診時立即做出基於數據的治療決策。隨著越來越多的獸醫院在不犧牲分析準確性的前提下優先考慮診斷速度，這項技術變革正獲得顯著的商業性動力。根據Investing.com網站2024年11月發表的題為「Zomedica公佈創紀錄的第三季度營收」的報導，Zomedica宣布其TRUFORMA平台在2024年第三季度的銷售額成長了80%，這證實了這些高精度診斷設備在獸醫實踐中的應用正在加速普及。

同時，用於早期疾病檢測的新型生物標記的商業化正在將市場從感染疾病管理擴展到腫瘤學和慢性病護理領域。在診斷領域，循環核小體和其他非侵入性標記的應用日益廣泛，使得在臨床症狀出現之前進行經濟實惠的常規癌症篩檢成為可能。這種向預防醫學的轉變將為診所創造新的、永續的收入來源，並透過早期療育顯著改善患者的治療效果。為了反映這種快速的市場滲透，VolitionRx Limited 在其於 2024 年 11 月發布的「2024 年第三季度財務業績和業務發展」報告中指出，該公司在 2024 年前九個月售出了超過 11 萬份 Nu.Q Vet 獸用癌症檢測產品，與去年同期相比，第三季度銷售額成長了 307%。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球獸用免疫診斷市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品類型（分析儀器、耗材）
    • 動物種類（家畜（牛、豬、家禽等）、伴侶動物（貓、馬、狗等））
    • 依技術（酵素連結免疫檢測化學冷光試驗、化學發光免疫測定、螢光免疫分析、比色免疫檢測）
    • 依應用領域（感染疾病、自體免疫疾病、內分泌學、腫瘤學、骨骼和礦物質疾病、其他）
    • 依最終使用者分類（檢測實驗室、學術/研究機構、獸醫院/診所、照護現場/內部檢測）
    • 分銷通路（醫院、零售店、藥局/藥局、電子商務）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美獸用免疫診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲獸用免疫診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區獸用免疫診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲獸用免疫診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲獸醫免疫診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球獸用免疫診斷市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Zoetis Inc.
  • IDEXX Laboratories, Inc.
  • Abaxis, Inc.
  • Biogal-Galed Labs Ltd.
  • Boehringer Ingelheim Animal Health GmbH
  • Thermo Fisher Scientific Inc.
  • Heska Corporation
  • Virbac SA
  • Merial Limited
  • Agrolabo SpA

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 7352

The Global Veterinary Immunodiagnostics Market is projected to expand from USD 2.94 Billion in 2025 to USD 4.66 Billion by 2031, achieving a compound annual growth rate of 7.98%. This specialized sector of animal healthcare employs antigen-antibody interactions to identify infectious pathogens, measure hormone levels, and assess immune responses across both livestock and companion animals. Growth in this market is primarily fueled by an increasing global pet population and the escalating need for efficient food animal production, both of which demand rigorous disease surveillance. These drivers are further bolstered by the rising incidence of zoonotic diseases, establishing a fundamental need for precise screening tools that goes beyond temporary trends. The sector's economic strength is significant; the American Pet Products Association reported that veterinary care and product sales in the United States hit $39.8 billion in 2024.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.94 Billion
Market Size 2031USD 4.66 Billion
CAGR 2026-20317.98%
Fastest Growing SegmentAnalyzers
Largest MarketNorth America

However, a significant impediment to broader market expansion is the prohibitive cost associated with advanced immunodiagnostic assays, which restricts their accessibility in price-sensitive regions. While developed markets continue to integrate these diagnostic modalities, the financial burden remains a barrier for smaller veterinary practices and developing economies. This challenge is frequently compounded by a scarcity of veterinary professionals trained to interpret complex diagnostic results, thereby limiting the universal penetration of high-precision immunodiagnostic technologies.

Market Driver

The surge in pet ownership and the humanization of animals serves as a major engine for the Global Veterinary Immunodiagnostics Market, reshaping the economics of veterinary care. As owners increasingly treat pets as family members, there is a growing willingness to fund preventative healthcare and advanced diagnostics. This trend is financially supported by the booming pet insurance industry, which helps offset costs for complex testing. The North American Pet Health Insurance Association's '2024 State of the Industry Report' noted that total pet health insurance premiums in the U.S. reached $3.9 billion in 2023, showing double-digit growth. This rise in insured pets correlates directly with increased use of immunodiagnostic panels, allowing veterinarians to order comprehensive diagnostics with higher confidence in client compliance and reimbursement.

Concurrently, the increasing prevalence of zoonotic and infectious animal diseases creates an urgent demand for rapid and sensitive detection tools in both the companion animal and livestock sectors. Transboundary pathogens pose threats to public health and global food security, requiring robust surveillance based on immunodiagnostic technology. A clear example of this risk occurred when the USDA Animal and Plant Health Inspection Service confirmed the detection of Highly Pathogenic Avian Influenza in dairy herds in April 2024, prompting immediate demand for targeted testing. The scale of these market forces is reflected in industry financial results; IDEXX Laboratories reported annual revenues of $3.66 billion for 2023 in their February 2024 results, highlighting the substantial value driven by the demand for veterinary diagnostics.

Market Challenge

The prohibitive cost associated with advanced immunodiagnostic assays stands as a primary obstruction to the expansive growth of the Global Veterinary Immunodiagnostics Market. While these diagnostic tools offer high precision for detecting pathogens and immune responses, their elevated pricing structure severely restricts their adoption, particularly within price-sensitive geographies and smaller independent veterinary practices. This financial barrier forces veterinarians and livestock producers to prioritize essential treatments over rigorous screening, leading to a lower volume of test utilization. Consequently, the market faces a bottleneck where the technological capability to detect diseases exists, but the economic capacity to deploy these tools at scale is absent, thereby stalling potential revenue streams in developing economies.

This economic strain directly correlates with reduced veterinary engagement, which hampers the overall demand for diagnostic consumption. When pet owners and producers face rising healthcare expenses, routine and diagnostic visits are often the first to be curtailed. According to the American Veterinary Medical Association, in 2024, patient visits to veterinary practices decreased by 2.3% compared to the previous year. This decline in clinical foot traffic inevitably results in fewer diagnostic panels being run, directly reducing the serviceable addressable market for immunodiagnostic products. As long as these assays remain financially out of reach for a significant portion of the global veterinary sector, the market's growth trajectory will remain constrained by these affordability thresholds.

Market Trends

The emergence of biosensor-based immunodiagnostic technologies is revolutionizing veterinary practice by delivering reference-laboratory precision directly at the point of care. Unlike standard lateral flow assays, these advanced platforms utilize technologies such as Bulk Acoustic Wave (BAW) sensors to detect hormones and pathogens with superior sensitivity, enabling immediate, data-driven treatment decisions during patient visits. This technological shift is gaining significant commercial traction as clinics increasingly prioritize diagnostic speed without compromising analytical accuracy. According to Investing.com, November 2024, in the 'Zomedica reports record Q3 revenue' article, Zomedica announced an 80% increase in TRUFORMA platform sales for the third quarter of 2024, validating the accelerating adoption of these high-precision diagnostic instruments in veterinary settings.

Simultaneously, the commercialization of novel biomarkers for early disease detection is expanding the market's scope beyond infectious disease management into oncology and chronic care. Diagnostics are increasingly utilizing circulating nucleosomes and other non-invasive markers to facilitate affordable, routine screening of cancers before clinical symptoms manifest. This transition towards preventative medicine generates new recurring revenue streams for practices while significantly improving patient prognoses through earlier intervention. Highlighting this rapid market uptake, according to VolitionRx Limited, November 2024, in the 'Third Quarter 2024 Financial Results and Business Update', the company reported selling over 110,000 Nu.Q Vet Cancer Tests in the first nine months of 2024, with Q3 revenue rising 307% year-over-year.

Key Market Players

  • Zoetis Inc.
  • IDEXX Laboratories, Inc.
  • Abaxis, Inc.
  • Biogal-Galed Labs Ltd.
  • Boehringer Ingelheim Animal Health GmbH
  • Thermo Fisher Scientific Inc.
  • Heska Corporation
  • Virbac S.A.
  • Merial Limited
  • Agrolabo S.p.A.

Report Scope

In this report, the Global Veterinary Immunodiagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Immunodiagnostics Market, By Product Type

  • Analyzers
  • Consumables

Veterinary Immunodiagnostics Market, By Animal Type

  • Livestock (Cattle)
  • Pigs
  • Poultry
  • Others
  • Companion (Feline)
  • Equine
  • Canine
  • Others

Veterinary Immunodiagnostics Market, By Technology

  • ELISA
  • Chemiluminescence Immunoassay
  • Fluorescent Immunoassay
  • Colorimetric Immunoassay
  • Radioimmunoassay
  • Rapid Tests
  • Others

Veterinary Immunodiagnostics Market, By Application

  • Infectious Disease
  • Autoimmune Disorder
  • Endocrinology
  • Oncology
  • Bone and Mineral Diseases
  • Others

Veterinary Immunodiagnostics Market, By End User

  • Reference Laboratories
  • Academic and Research Institutes
  • Veterinary Hospitals & Clinics
  • Point of care/In-house testing

Veterinary Immunodiagnostics Market, By Distribution Channel

  • Hospitals
  • Retail Stores
  • Pharmacies & Drug Stores
  • E-Commerce

Veterinary Immunodiagnostics Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Immunodiagnostics Market.

Available Customizations:

Global Veterinary Immunodiagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Immunodiagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Analyzers, Consumables)
    • 5.2.2. By Animal Type (Livestock (Cattle, Pigs, Poultry, Others), Companion (Feline, Equine, Canine, Others))
    • 5.2.3. By Technology (ELISA, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Colorimetric Immunoassay)
    • 5.2.4. By Application (Infectious Disease, Autoimmune Disorder, Endocrinology, Oncology, Bone and Mineral Diseases, Others)
    • 5.2.5. By End User (Reference Laboratories, Academic and Research Institutes, Veterinary Hospitals & Clinics, Point of care/In-house testing)
    • 5.2.6. By Distribution Channel (Hospitals, Retail Stores, Pharmacies & Drug Stores, E-Commerce)
    • 5.2.7. By Region
    • 5.2.8. By Company (2025)
  • 5.3. Market Map

6. North America Veterinary Immunodiagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Animal Type
    • 6.2.3. By Technology
    • 6.2.4. By Application
    • 6.2.5. By End User
    • 6.2.6. By Distribution Channel
    • 6.2.7. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Veterinary Immunodiagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Animal Type
        • 6.3.1.2.3. By Technology
        • 6.3.1.2.4. By Application
        • 6.3.1.2.5. By End User
        • 6.3.1.2.6. By Distribution Channel
    • 6.3.2. Canada Veterinary Immunodiagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Animal Type
        • 6.3.2.2.3. By Technology
        • 6.3.2.2.4. By Application
        • 6.3.2.2.5. By End User
        • 6.3.2.2.6. By Distribution Channel
    • 6.3.3. Mexico Veterinary Immunodiagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Animal Type
        • 6.3.3.2.3. By Technology
        • 6.3.3.2.4. By Application
        • 6.3.3.2.5. By End User
        • 6.3.3.2.6. By Distribution Channel

7. Europe Veterinary Immunodiagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Animal Type
    • 7.2.3. By Technology
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Distribution Channel
    • 7.2.7. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Veterinary Immunodiagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Animal Type
        • 7.3.1.2.3. By Technology
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
        • 7.3.1.2.6. By Distribution Channel
    • 7.3.2. France Veterinary Immunodiagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Animal Type
        • 7.3.2.2.3. By Technology
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
        • 7.3.2.2.6. By Distribution Channel
    • 7.3.3. United Kingdom Veterinary Immunodiagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Animal Type
        • 7.3.3.2.3. By Technology
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User
        • 7.3.3.2.6. By Distribution Channel
    • 7.3.4. Italy Veterinary Immunodiagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Animal Type
        • 7.3.4.2.3. By Technology
        • 7.3.4.2.4. By Application
        • 7.3.4.2.5. By End User
        • 7.3.4.2.6. By Distribution Channel
    • 7.3.5. Spain Veterinary Immunodiagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Animal Type
        • 7.3.5.2.3. By Technology
        • 7.3.5.2.4. By Application
        • 7.3.5.2.5. By End User
        • 7.3.5.2.6. By Distribution Channel

8. Asia Pacific Veterinary Immunodiagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Animal Type
    • 8.2.3. By Technology
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Distribution Channel
    • 8.2.7. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Veterinary Immunodiagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Animal Type
        • 8.3.1.2.3. By Technology
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
        • 8.3.1.2.6. By Distribution Channel
    • 8.3.2. India Veterinary Immunodiagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Animal Type
        • 8.3.2.2.3. By Technology
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
        • 8.3.2.2.6. By Distribution Channel
    • 8.3.3. Japan Veterinary Immunodiagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Animal Type
        • 8.3.3.2.3. By Technology
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
        • 8.3.3.2.6. By Distribution Channel
    • 8.3.4. South Korea Veterinary Immunodiagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Animal Type
        • 8.3.4.2.3. By Technology
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
        • 8.3.4.2.6. By Distribution Channel
    • 8.3.5. Australia Veterinary Immunodiagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Animal Type
        • 8.3.5.2.3. By Technology
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User
        • 8.3.5.2.6. By Distribution Channel

9. Middle East & Africa Veterinary Immunodiagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Animal Type
    • 9.2.3. By Technology
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Distribution Channel
    • 9.2.7. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Veterinary Immunodiagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Animal Type
        • 9.3.1.2.3. By Technology
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
        • 9.3.1.2.6. By Distribution Channel
    • 9.3.2. UAE Veterinary Immunodiagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Animal Type
        • 9.3.2.2.3. By Technology
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
        • 9.3.2.2.6. By Distribution Channel
    • 9.3.3. South Africa Veterinary Immunodiagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Animal Type
        • 9.3.3.2.3. By Technology
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User
        • 9.3.3.2.6. By Distribution Channel

10. South America Veterinary Immunodiagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Animal Type
    • 10.2.3. By Technology
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Distribution Channel
    • 10.2.7. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Veterinary Immunodiagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Animal Type
        • 10.3.1.2.3. By Technology
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
        • 10.3.1.2.6. By Distribution Channel
    • 10.3.2. Colombia Veterinary Immunodiagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Animal Type
        • 10.3.2.2.3. By Technology
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
        • 10.3.2.2.6. By Distribution Channel
    • 10.3.3. Argentina Veterinary Immunodiagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Animal Type
        • 10.3.3.2.3. By Technology
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User
        • 10.3.3.2.6. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Veterinary Immunodiagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Zoetis Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. IDEXX Laboratories, Inc.
  • 15.3. Abaxis, Inc.
  • 15.4. Biogal-Galed Labs Ltd.
  • 15.5. Boehringer Ingelheim Animal Health GmbH
  • 15.6. Thermo Fisher Scientific Inc.
  • 15.7. Heska Corporation
  • 15.8. Virbac S.A.
  • 15.9. Merial Limited
  • 15.10. Agrolabo S.p.A.

16. Strategic Recommendations

17. About Us & Disclaimer